168 related articles for article (PubMed ID: 29653480)
1. Changes in Macrolide Resistance Among Group A Streptococci in Serbia and Clonal Evolution of Resistant Isolates.
Gajic I; Mijac V; Ranin L; Grego E; Kekic D; Jegorovic B; Smitran A; Popovic S; Opavski N
Microb Drug Resist; 2018 Nov; 24(9):1326-1332. PubMed ID: 29653480
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of macrolide resistant Streptococcus pyogenes isolates from pharyngitis patients in Serbia.
Opavski N; Gajic I; Borek AL; Obszańska K; Stanojevic M; Lazarevic I; Ranin L; Sitkiewicz I; Mijac V
Infect Genet Evol; 2015 Jul; 33():246-52. PubMed ID: 25976381
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology, antimicrobial susceptibility, and characterization of macrolide-resistant Streptococcus pyogenes in Japan.
Tanaka Y; Gotoh K; Teramachi M; Ishimoto K; Tsumura N; Shindou S; Yamashita Y
J Infect Chemother; 2016 Nov; 22(11):727-732. PubMed ID: 27645122
[TBL] [Abstract][Full Text] [Related]
4. Molecular emm typing of Bulgarian macrolide-resistant Streptococcus pyogenes isolates.
Muhtarova A; Mihova K; Markovska R; Mitov I; Kaneva R; Gergova R
Acta Microbiol Immunol Hung; 2019 Dec; 67(1):14-17. PubMed ID: 31833385
[TBL] [Abstract][Full Text] [Related]
5. Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece.
Syrogiannopoulos GA; Grivea IN; Al-Lahham A; Panagiotou M; Tsantouli AG; Michoula Ralf René Reinert AN; van der Linden M
PLoS One; 2013; 8(8):e71558. PubMed ID: 23977078
[TBL] [Abstract][Full Text] [Related]
6. Macrolide-resistant Streptococcus pyogenes from Chinese pediatric patients in association with Tn916 transposons family over a 16-year period.
Feng L; Lin H; Ma Y; Yang Y; Zheng Y; Fu Z; Yu S; Yao K; Shen X
Diagn Microbiol Infect Dis; 2010 Aug; 67(4):369-75. PubMed ID: 20638606
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of macrolide resistance in Streptococcus pyogenes collected in Serbia.
Pavlovic L; Grego E; Sipetic-Grujicic S
Jpn J Infect Dis; 2010 Jul; 63(4):275-6. PubMed ID: 20657068
[TBL] [Abstract][Full Text] [Related]
8. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
[TBL] [Abstract][Full Text] [Related]
9. emm Types and clusters and macrolide resistance of pediatric group A streptococcal isolates in Central Greece during 2011-2017.
Grivea IN; Syrogiannopoulos GA; Michoula AN; Gazeti G; Malli E; Tsilipounidaki K; Fouzas S; Anthracopoulos MB; Petinaki E
PLoS One; 2020; 15(5):e0232777. PubMed ID: 32379802
[TBL] [Abstract][Full Text] [Related]
10. Typing of macrolide resistant group A streptococci by random amplified polymorphic DNA analysis.
Gajic I; Mijac V; Stanojevic M; Ranin L; Smitran A; Opavski N
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2960-5. PubMed ID: 25339493
[TBL] [Abstract][Full Text] [Related]
11. Evolution of macrolide resistance in Streptococcus pyogenes over 14 years in an area of central Italy.
Olivieri R; Morandi M; Zanchi A; Tordini G; Pozzi G; De Luca A; Montagnani F
J Med Microbiol; 2015 Oct; 64(10):1186-1195. PubMed ID: 26224594
[TBL] [Abstract][Full Text] [Related]
12. The trend of macrolide resistance and emm types of group A streptococci from children at a medical center in southern Taiwan.
Chuang PK; Wang SM; Lin HC; Cho YH; Ma YJ; Ho TS; Shen CF; Liu CC
J Microbiol Immunol Infect; 2015 Apr; 48(2):160-7. PubMed ID: 24094501
[TBL] [Abstract][Full Text] [Related]
13. Macrolide-resistant genes of Streptococcus pyogenes isolated from the upper respiratory tract by polymerase chain reaction.
Billal DS; Hotomi M; Yamauchi K; Fujihara K; Tamura S; Kuki K; Sugita R; Endou M; Mukaigawa J; Yamanaka N
J Infect Chemother; 2004 Apr; 10(2):115-20. PubMed ID: 15160306
[TBL] [Abstract][Full Text] [Related]
14. [Macrolide resistance phenotypes and genotypes in group G streptococci].
Açikgöz ZC; Göçer S; Almayanlar E
Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
[TBL] [Abstract][Full Text] [Related]
15. Macrolide- and tetracycline-resistance determinants of colonizing group B streptococcus in women in Egypt.
Shabayek S; Abdalla S
J Med Microbiol; 2014 Oct; 63(Pt 10):1324-1327. PubMed ID: 25053798
[TBL] [Abstract][Full Text] [Related]
16. Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.
Gherardi G; Petrelli D; Di Luca MC; Pimentel de Araujo F; Bernaschi P; Repetto A; Bellesi J; Vitali LA
Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1797-802. PubMed ID: 26024763
[TBL] [Abstract][Full Text] [Related]
17. Changes in epidemiologic characteristics and antimicrobial resistance of
Ubukata K; Wajima T; Morozumi M; Sakuma M; Tajima T; Matsubara K; Itahashi K; Iwata S
J Med Microbiol; 2020 Mar; 69(3):443-450. PubMed ID: 32011228
[No Abstract] [Full Text] [Related]
18. What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.
Montes M; Tamayo E; Mojica C; García-Arenzana JM; Esnal O; Pérez-Trallero E
J Antimicrob Chemother; 2014 Jun; 69(6):1474-82. PubMed ID: 24562616
[TBL] [Abstract][Full Text] [Related]
19. [Phenotypes and mechanisms of resistance to macrolides and lincosamides in Streptococcus agalactiae isolates with clinical significance in an eight-year period (2002-2010)].
Campelo FA; Pedrosa AC; Antúnez IÁ; Capuz BL
Rev Esp Quimioter; 2012 Mar; 25(1):42-6. PubMed ID: 22488541
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China.
Li H; Zhou L; Zhao Y; Ma L; Liu X; Hu J
BMC Infect Dis; 2020 Jul; 20(1):507. PubMed ID: 32660436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
